| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681769 | Clinical Neurology and Neurosurgery | 2018 | 12 Pages |
Abstract
Our findings demonstrate an improved change in GCS and GOS for those positive with METH than those without. Surprisingly, substance positive patients did not have a worse outcome score. Further investigation is necessary to evaluate the potential neuro-protective effects of METH in TBI.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jason Duong, Christopher Elia, Ariel Takayanagi, Taylor Lanzilotta, Ajay Ananda, Dan Miulli,